Estrogen receptor beta agonists as anti-tumor and immune-modulatory agents in malignant glioma.

被引：0
|
作者：
Isaacs, Jordan Fredriksen [1 ]
Ravi, Divya [1 ]
Del Genio, Carmen L. [2 ]
Shalit, Zachary A. [1 ]
Micalizio, Glenn C. [1 ]
Gaur, Arti B. [1 ]
机构：
[1] Dartmouth Coll, Hanover, NH 03755 USA
[2] Dartmouth Hitchcock, Lebanon, NH USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1701
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
    Heinz Läubli
    Philipp Müller
    Lucia D’Amico
    Mélanie Buchi
    Abhishek S. Kashyap
    Alfred Zippelius
    Cancer Immunology, Immunotherapy, 2018, 67 : 815 - 824
  • [42] The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
    Laubli, Heinz
    Mueller, Philipp
    D'Amico, Lucia
    Buchi, MeLanie
    Kashyap, Abhishek S.
    Zippelius, Alfred
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (05) : 815 - 824
  • [43] Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer
    Matsushima, Hiroshi
    Mori, Taisuke
    Ito, Fumitake
    Yamamoto, Takuro
    Akiyama, Makoto
    Kokabu, Tetsuya
    Yoriki, Kaori
    Umemura, Shiori
    Akashi, Kyoko
    Kitawaki, Jo
    ONCOTARGET, 2016, 7 (23) : 34131 - 34148
  • [44] ONO-AE3-208 PROMOTES ANTI-TUMOR IMMUNE ACTIVITY AND SURVIVAL IN GLIOMA MODELS
    Kohanbash, Gary
    Kotani, Tohru
    Chuntova, Pavlina
    Shoger, Karsen
    Jahan, Naznin
    Shrivastav, Shruti
    Carrera, Diego
    Downey, Kira
    Castro, Brandyn
    Takeda, Kazuhiko
    Okada, Hideho
    NEURO-ONCOLOGY, 2017, 19 : 122 - 122
  • [45] Regulation of Anti-Tumor Immune Response by EphA2 Receptor Tyrosine Kinase
    Shi, Xioajun Roger
    Lingerak, Ryan
    Kim, Soyeon
    Wang, Bingcheng
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [46] RECOMBINANT INTERLEUKIN-7 ENHANCES THE ANTI-TUMOR IMMUNITY OF A DENDRITIC CELL VACCINE IN A MURINE MALIGNANT GLIOMA
    Oh, Sol Hooy
    Ahn, Stephen
    Park, Jae Sung
    Hong, Yong Kil
    Jeon, Sin-Soo
    NEURO-ONCOLOGY, 2019, 21 : 158 - 158
  • [47] INCREASED VOLUMES OF MITOCHONDRIA AND GRANULAR ENDOPLASMIC-RETICULUM IN RAT GLIOMA CELLS TREATED WITH ANTI-TUMOR AGENTS
    GRASSO, RJ
    MOORE, NA
    BOLER, RK
    JOHNSON, CE
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1977, 155 (02): : 219 - 224
  • [48] SUSCEPTIBILITIES OF NORMAL AND MALIGNANT HUMAN LUNG-CELLS IN CULTURE TO CYTOCIDAL ACTION OF ANTI-TUMOR AGENTS
    TSUKEDA, H
    MIZUNO, S
    NITTA, K
    CANCER RESEARCH, 1978, 38 (08) : 2529 - 2532
  • [49] Nanoparticle-mediated systemic delivery of immune agonists to tumors enabling anti-tumor efficacy without toxicity
    Zhang, Yuan
    Irvine, Darrell J.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [50] NUCLEOSIDE CONJUGATES AS POTENTIAL ANTI-TUMOR AGENTS .3. SYNTHESIS AND ANTI-TUMOR ACTIVITY OF "1-(BETA-D-ARABINOFURANOSYL)CYTOSINE CONJUGATES OF CORTICOSTEROIDS
    HONG, CI
    NECHAEV, A
    KIRISITS, AJ
    BUCHHEIT, DJ
    WEST, CR
    JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (12) : 1343 - 1347
12345